A Phase Ⅰb/Ⅱ Clinical Study of SHR-A1811 Combined With Other Therapies in Patients With HER2 Low Advanced or Metastatic Breast Cancer.
Clinical trial NCT05792410 · UNKNOWN
Trial details
- NCT number
- NCT05792410
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-01
- Primary completion
- 2024-02-27
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.